EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Inhalable Albumin Nanoparticles Co-Delivering Dihydroartemisinin and Nintedanib Attenuate Pulmonary Fibrosis by Suppressing TGF-β1/Smad2/3 Signaling

Caopei Zheng iD, Wei Ding, Yuqing Sun, Yu Wang iD, Yulin Zhang iD

International Journal of Nanomedicine · 2026

DOI: 10.2147/ijn.s576680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Caopei Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Artemisinins, Indoles, Pulmonary Fibrosis, Nanoparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtemisininsIndolesPulmonary FibrosisNanoparticlesAnimalsTransforming Growth Factor beta1MiceSignal TransductionHumansSmad3 ProteinSmad2 ProteinAdministration, InhalationParticle SizeMice, Inbred C57BLMaleLungBleomycin

Stichwörter der Autor:innen

albumin carrierdihydroartemisinininhalable nanoparticlesnintedanibpulmonary fibrosis

Substanzen

ArtemisininsIndolesartenimolTransforming Growth Factor beta1nintedanibSmad3 ProteinSmad2 ProteinSmad2 protein, mouseSmad3 protein, mouseBleomycin

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Laboratory for Clinical Medicine, Capital Medical University, Beijing, People's Republic of China.
  • Clinical Trial Institution Office, Beijing Jishuitan Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Beijing Research Center for Respiratory Infectious Diseases, Beijing, People's Republic of China.

ORCID-Profile: Caopei Zheng, Yu Wang, Yulin Zhang

Zitieren

APA

Zheng, C., Ding, W., Sun, Y., Wang, Y., & Zhang, Y. (2026). Inhalable Albumin Nanoparticles Co-Delivering Dihydroartemisinin and Nintedanib Attenuate Pulmonary Fibrosis by Suppressing TGF-β1/Smad2/3 Signaling. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s576680

Vancouver

Zheng C, Ding W, Sun Y, Wang Y, Zhang Y. Inhalable Albumin Nanoparticles Co-Delivering Dihydroartemisinin and Nintedanib Attenuate Pulmonary Fibrosis by Suppressing TGF-β1/Smad2/3 Signaling. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s576680

BibTeX
@article{Zheng2026,
  author = {Zheng, Caopei and Ding, Wei and Sun, Yuqing and Wang, Yu and Zhang, Yulin},
  title = {Inhalable Albumin Nanoparticles Co-Delivering Dihydroartemisinin and Nintedanib Attenuate Pulmonary Fibrosis by Suppressing TGF-β1/Smad2/3 Signaling},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  doi = {10.2147/ijn.s576680}
}
Kostenlos starten →